Etanercept treatment in corticosteroid-dependent myasthenia gravis
Abstract
The authors report a prospective pilot trial of etanercept in corticosteroid-dependent autoimmune myasthenia gravis. Eleven patients were enrolled, with eight completing the 6-month trial. Two patients were withdrawn owing to disease worsening, and one patient was withdrawn because of an erythematous skin rash. Six of the eight patients who completed the trial improved, based on quantitative measures of muscle strength and lowering of corticosteroid requirement.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Lindstrom J, Shelton D, Fujii Y. Myasthenia gravis. Adv Immunol. 1998; 42: 233–284.
2.
Goluszko E, Hjelmstrom P, Deng C, Poussin M, Ruddle NH, Christadoss P. Lymphotoxin-alpha deficiency completely protects C57BL/6 mice from developing experimental autoimmune myasthenia gravis. J Neuroimmunol. 2001; 113: 109–118.
3.
Goluszko E, Deng C, Poussin MA, Christadoss P. Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis. J Neuroimmunol. 2002; 122: 85–93.
4.
Wang HB, Li H, Shi FD, Chambers BJ, Link H, Ljunggren HG. Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis. Int Immunol. 2000; 12: 1381–1388.
5.
Christadoss P, Goluszko E. Treatment of experimental autoimmune myasthenia gravis with recombinant tumor necrosis factor receptor Fc protein. J Neuroimmunol. 2002; 122: 186–190.
6.
Jaretzki A, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis. Recommendations for clinical research standards. Neurology. 2000; 55: 16–23.
7.
Sanders DB, Tucker-Lipscomb B, Massey JM. A simple manual muscle test for myasthenia gravis. Validation and comparison with the QMG score. Ann NY Acad Sci. 2003; 998: 440–444.
8.
Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology. 1999; 52: 1487–1489.
9.
Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the quantitative myasthenia gravis score. Ann NY Acad Sci. 1998; 841: 769–772.
10.
Zou JX, Rudwaleit M, Brandt J, Thiel A, Braun J, Sieper J. Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept. Ann Rheum Dis. 2003; 62: 561–564.
Information & Authors
Information
Published In
Copyright
© 2004.
Publication History
Received: May 11, 2004
Accepted: August 2, 2004
Published online: December 28, 2004
Published in print: December 28, 2004
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Transcriptional landscape of myasthenia gravis revealed by weighted gene coexpression network analysis, Frontiers in Genetics, 14, (2023).https://doi.org/10.3389/fgene.2023.1106359
- Childhood myasthenia gravis in Japan : Pathophysiology and treatment options , Clinical and Experimental Neuroimmunology, 14, 4, (185-194), (2023).https://doi.org/10.1111/cen3.12762
- A series of patients with refractory myasthenia gravis, Neurología (English Edition), 38, 4, (256-261), (2023).https://doi.org/10.1016/j.nrleng.2023.04.001
- Descripción de una serie de pacientes con miastenia gravis refractaria, Neurología, 38, 4, (256-261), (2023).https://doi.org/10.1016/j.nrl.2020.08.016
- Long-term efficacy and safety of tacrolimus in young children with myasthenia gravis, Journal of Clinical Neuroscience, 116, (93-98), (2023).https://doi.org/10.1016/j.jocn.2023.08.022
- Treatment and Management of Disorders of the Neuromuscular Junction, Neuromuscular Disorders, (446-491), (2022).https://doi.org/10.1016/B978-0-323-71317-7.00019-6
- Principles and Guidelines of Immunotherapy in Neuromuscular Disorders, Neuromuscular Disorders, (143-159), (2022).https://doi.org/10.1016/B978-0-323-71317-7.00007-X
- Clinical Classification and Scales for Myasthenia Gravis, Journal of the Korean Neurological Association, 39, 2 Suppl, (87-92), (2021).https://doi.org/10.17340/jkna.2021.2.23
- Adalimumab-induced myasthenia gravis: case-based review, Rheumatology International, 40, 11, (1891-1894), (2020).https://doi.org/10.1007/s00296-020-04587-4
- Myasthenia gravis and specific immunotherapy: monoclonal antibodies, Annals of the New York Academy of Sciences, 1452, 1, (18-33), (2019).https://doi.org/10.1111/nyas.14195
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.